About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
PRAH - PRA Health Sciences| Previous Close | $144.33 | Open | $144.88 |
| Volume | 1.3M | Market Cap | 9.456B |
| Yield | Last Dividend |
| PRA HEALTH SCIENCES INVESTOR ALERT by Th... | 03/01/21 |
| NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (???KSF???) a... | |
| PRA Health Sciences To Be Acquired By IC... | 02/25/21 |
| hares of PRA Health Sciences jumped nearly 18.7% on Feb. The post PRA Health Sciences To Be Acquired By ICON For $12B; Shares Pop 19% appeared first o... | |
| Verisk, Parsons Fall; PRA Health Science... | 02/24/21 |
| Stocks that traded heavily or had substantial price changes Wednesday: | |
| SHAREHOLDER ALERT: WeissLaw LLP Investig... | 02/24/21 |
| NEW YORK, Feb. 24, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of ... | |
| Why Sunesis, Poseida, Salarius And PRA H... | 02/24/21 |
| A slew of healthcare stocks is moving on Wednesday in reaction to company-specific catalysts. Sunesis Rises On Hopes of Completion of Merger Deal: Sun... | |
| In the biggest CRO takeover in years, Ic... | 02/24/21 |
| Contract research M&A had a healthy run in recent years before recently petering out. But with the market ripe for a big buyout and the Covid-19 pande... | |
| PRA Health Sciences Merger Investigation... | 02/24/21 |
| NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of PRA Health Sciences, Inc. (NASDAQ... | |
| ICON to Buy PRA Health in $12 Billion Ca... | 02/24/21 |
| Drug and medical device maker ICON agrees to buy PRA Health Sciences in a cash-and-stock transaction valued at about $12 billion. | |
| PRA Health Sciences, Inc. Reports Fourth... | 02/24/21 |
| Net new business of $872.4 million in the fourth quarter excluding reimbursement revenue; representing growth of 32.4%; Net book-to-bill of 1.42Net ne... | |
| ICON to Acquire PRA Health Sciences, Cre... | 02/24/21 |
| DUBLIN--(BUSINESS WIRE)--ICON to acquire PRA Health Sciences, creating a world leader in Healthcare Intelligence and Clinical Research | |
| Contract Research Organizations Market S... | 02/03/21 |
| Contract Research Organizations Market Size, Share, Analysis 2027 | Top key players ??? Laboratory Corporation Of America Holdings (covance), Iqvia, S... | |
| The Daily Biotech Pulse: Fluidigm's Sali... | 01/22/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 21) Aca... | |
| The Daily Biotech Pulse: Bausch Health I... | 01/13/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 12) Abb... | |
| Contract Research Organization Market to... | 01/11/21 |
| ReportsnReports.com the exclusive leading provider of market research reports published research report on ???China Contract Research Organization (CR... | |
| Pre Clinical CROs market 2027 Top Player... | 12/09/20 |
| The global Pre Clinical CROs market is expected to reach US$ 8,412.9 Mn in 2027 from US$ 4,282.4 Mn in 2018. The market is estimated to grow with a CA... | |
| Contract Research Organizations Services... | 12/09/20 |
| Reportsandmarkets.com adds ???Global Contract Research Organizations Services Market Insights, Forecast to 2025??? new report to its research database... | |
| Innovative Research Report on Virtual Cl... | 11/19/20 |
| Global Virtual Clinical Trials Market Report is recently published by Future Business Insights is a value addition to the studied Market. The compilat... | |
| PRA Health Sciences Reports Strong First... | 11/04/20 |
| PRA Health Sciences announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by??? | |
| PRA Health Sciences, Inc. (NASDAQ:PRAH) ... | 10/23/20 |
| Analysts expect that PRA Health Sciences, Inc. (NASDAQ:PRAH) will report sales of $767.84 million for the current fiscal quarter, Zacks reports. Five ... | |
| PRA Health Sciences, Inc. (NASDAQ:PRAH) ... | 10/23/20 |
| Shares of PRA Health Sciences, Inc. (NASDAQ:PRAH) have received a consensus recommendation of ???Hold??? from the fifteen research firms that are pres... | |
| PRA Health Sciences, Inc. (NASDAQ:PRAH) ... | 10/22/20 |
| Wall Street analysts expect PRA Health Sciences, Inc. (NASDAQ:PRAH) to post $1.13 earnings per share for the current quarter, according to Zacks. Five... | |
| Pre Clinical CROs Market Expected To Rea... | 10/22/20 |
| Pre Clinical CROs Market Expected To Be US$ 4,282.42 Mn In 2018 And Is Predicted To Grow At A CAGR Of 8.1% During The Forecast Period 2019 ??? 2027, T... | |
| The Daily Biotech Pulse: Vertex Pulls Pl... | 10/15/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 14) 10X... | |
| U.S. Contract Research Organization (CRO... | 10/11/20 |
| CMI Research added a comprehensive research document of 200+ pages on the ???U.S. Contract Research Organization (CROs) Market??? with detailed insigh... | |
| PRA Health Sciences and Deep Lens announ... | 09/18/20 |
| The two companies bring together cloud-based mobile technologies to improve the identification, screening and matching of patients to precision-based ... | |
| PRA Health Sciences Joins The Leukemia &... | 09/03/20 |
| RYE BROOK, N.Y. and RALEIGH, N.C., Sept. 3, 2020 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) and PRA Health Sciences (NASDAQ: PRAH) announce... | |
| PRA Health Sciences ready to navigate RA... | 06/18/20 |
| U.S. law requiring clinical research for pediatric oncology treatments goes into effect mid-August 2020 | |
| Why Is PRA Health Sciences (PRAH) Up 7.3... | 05/30/20 |
| PRA Health Sciences (PRAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| PRA Health Sciences (PRAH) Surpasses Q1 ... | 04/30/20 |
| PRA Health Sciences (PRAH) delivered earnings and revenue surprises of 0.96% and 3.04%, respectively, for the quarter ended March 2020. Do the numbers... | |
| Will PRA Health Sciences (PRAH) Beat Est... | 04/29/20 |
| PRA Health Sciences (PRAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a ... | |
| Date | 2021-02-24 (AMC) | Est. (EPS/Rev.) | $1.47/ 829.02M |
| Actual (EPS/Rev.) | $1.55/ $873.46 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Fibonacci Trading | Arez | 56.00 % | Subscribe |
| TopFlight Trades - Premium (Options) | Eric Cunningham | 51.00 % | Follow |
| TopFlight Trades - Premium (Stocks) | Eric Cunningham | 38.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
